Alcon AG

SIX:ALC

F. Michael Ball is a distinguished executive known for his leadership in the pharmaceutical and medical device industries. He served as the CEO of Alcon, a global leader in eye care, which specializes in providing innovative products and solutions to improve vision and eye health. Ball joined Alcon as CEO in 2016. During his tenure, he was instrumental in navigating Alcon through its separation from Novartis, a Swiss multinational pharmaceutical company, transforming it into an independent entity. This transition was a significant achievement, positioning Alcon to focus more strategically on its core areas in the ophthalmology sector. Before his time at Alcon, F. Michael Ball was the CEO of Hospira, a leading provider of injectable drugs and infusion technologies, where he successfully led the company until its acquisition by Pfizer in 2015. His leadership was marked by a strong emphasis on operational efficiency and strategic growth initiatives. Ball's career in the healthcare industry is extensive, with more than three decades of experience, including various senior leadership roles at companies such as Allergan, where he significantly contributed to the company's growth in the global pharmaceutical market. F. Michael Ball is recognized for his strategic acumen and ability to lead complex organizations, driving growth and innovation while responding effectively to industry challenges.

David J. Endicott is the Chief Executive Officer of Alcon AG, a global leader in eye care dedicated to helping people see brilliantly. Endicott joined Alcon in July 2016 as the Chief Operating Officer and became CEO in July 2018. Under his leadership, Alcon focuses on innovative products in surgical and vision care. He has extensive experience in the healthcare industry, having worked with various global medical device companies. Before joining Alcon, Endicott served in several senior roles at Hospira, Inc., including President of Hospira Medical Devices. He also held significant leadership positions at Allergan, where he was Corporate Vice President and President of Allergan's Medical Devices business. Endicott has a strong track record of driving growth and operational excellence. He holds a Bachelor of Science degree from Wake Forest University and an MBA from the University of Southern California (USC) Marshall School of Business. Through his career, Endicott has been recognized for his strategic vision and his commitment to advancing healthcare solutions.

Dr. Arthur B. Cummings is an accomplished ophthalmologist known for his expertise in refractive surgery and his association with Alcon AG, a global leader in eye care. Dr. Cummings has an impressive medical background and is recognized for his contributions to advancing ophthalmic procedures and technologies. He has been deeply involved in pioneering laser eye surgery techniques, including LASIK and refractive lens exchange, which have transformed vision correction practices. Beyond his surgical skills, Dr. Cummings is also known for his involvement in clinical research and education, contributing to numerous publications and presentations at international conferences. At Alcon AG, Dr. Cummings plays a key role in advising on the development and refinement of surgical technologies and solutions, aiming to improve patient outcomes and advance the field of ophthalmology. His work is highly regarded both within the company and the broader medical community.

Ian Bell is a prominent executive in the healthcare and medical device industry. He serves as the President of the Europe, Middle East, and Africa (EMEA) region at Alcon AG, a global leader in eye care dedicated to helping people see brilliantly. With a strong background in pharmaceutical and medical technology businesses, Ian Bell has brought significant expertise to Alcon's operations in this vital region. He joined Alcon with a wealth of experience gained from previous leadership roles in various companies within the healthcare sector. At Alcon, Bell is responsible for driving business growth and expanding the company's market presence across the EMEA region. His focus includes enhancing Alcon's portfolio of cutting-edge eye care products and ensuring that the company's innovative solutions are accessible to healthcare professionals and patients throughout these markets. Ian Bell's leadership is marked by a strategic vision and a commitment to improving eye health, which aligns with Alcon's mission to help people see brilliantly. His role is crucial in adapting the company's strategies to the diverse and complex markets within the EMEA region, maintaining Alcon's position as a leader in ophthalmic products and technology.

Margaret Buckley is a notable executive leader at Alcon AG, serving as the Chief Marketing Officer (CMO). With a rich background in marketing and a proven track record in healthcare, she plays a pivotal role in shaping the marketing strategies and initiatives for Alcon, a global leader in eye care. Buckley has extensive experience in the pharmaceutical and medical device industries, where she has consistently driven innovation and growth. Her leadership focuses on branding, digital marketing, and market expansion, helping Alcon maintain its position at the forefront of eye care technology and services. She is known for her strategic vision, her ability to lead high-performing teams, and her commitment to advancing eye health through effective marketing campaigns and partnerships. Through her efforts, Buckley contributes significantly to Alcon's mission of helping people see brilliantly.